AARTISURF NSI Week ended 07 Aug 2026

Weekly Investor Report

Aarti Surfactants Limited · Basic Materials · Specialty Chemicals

Open interactive chart View report data
Latest close 536.0 INR
33.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 35.3% above the Trend Line and sits at 89.0% of its 52-week range. The latest completed week returned 33.7%, after a 38.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 55/100.

Setup score 60 out of 100
Latest Close 536.0 INR 7 Aug 2026
1W Return 33.7% latest completed week
4W Return 38.5% short-term follow-through
12W Return 35.9% quarterly tape
Trend Breadth 1.9% 1 of 52 weeks active
Volume Ratio 9.6x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 31.12% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 33.7% Latest completed week; four-week move 38.5%. Indicator stack 5/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 31.12% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 55/100 14 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 35.3% above the Trend Line and sits at 89.0% of its 52-week range. The latest completed week returned 33.7%, after a 38.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 9.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.09

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals4Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 38.5% over four weeks, 35.9% over 12 weeks, and 12.1% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W33.7%
4W38.5%
12W35.9%
26W25.6%
52W12.1%
Active trend streak1 weeks
Active weeks in one year1
Trend breadth1.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.55Latest activity-pressure read.
Pressure change146.7%Four-week change in activity pressure.
Leadership29.59Latest relative-leadership reading.
RS change534.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength83/100Blend of value, momentum, and quality. Underlying universe rank 18; rank 1 is best.
Value86/100Relative valuation strength. Underlying universe rank 15; rank 1 is best.
Quality27/100Profitability and accounting quality. Underlying universe rank 74; rank 1 is best.
Momentum64/100Medium-term price momentum. Underlying universe rank 37; rank 1 is best.
Growth64/100Revenue and earnings growth. Underlying universe rank 37; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework48/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
36.8x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
11.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
15.8%
Gross profit retained from each unit of revenue.
Operating margin
3.4%
Operating profit retained from revenue.
Free-cash-flow margin
3.7%
Free cash flow generated from revenue.
Return on invested capital
6.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
30.4%
Latest one-year revenue growth.
EPS growth
-15.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.2%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 14 relevant articles.

6 positive · 6 neutral · 2 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.8%Distance below the 52-week high.
13-week volatility10.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+33.7%Week of 7 Aug.
Worst week-14.6%Week of 15 May.
Latest week+33.7%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses10
Sharp losses4
Recent vol10.4%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape51/100

Trend, activity pressure, participation, and risk combine to a 51/100 tape read.

 Indicator analysis35/100

Latest 12-week confirmation: trend 1/12, activity pressure 12/12, relative leadership 1/12.

Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 31.12%

Next-week expectancy is negative with a 31.12% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors64/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 17; Buyback Yield rank 65; Small Cap Core rank 24 SVQF48/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 817.5 of 1576 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment55/100

Weighted news tone is neutral across 14 relevant articles.

Aarti Surfactants consolidated net profit rises 206.12% in the June 2026 quarter Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026536.0 INR33.7%396.2 INR553.0 INR0.5529.591.2MOn
31 Jul 2026400.9 INR5.0%390.5 INR553.4 INR0.30-2.0879.4KOff
24 Jul 2026381.6 INR-2.7%390.1 INR554.7 INR0.16-5.0635.0KOff
17 Jul 2026392.3 INR1.4%390.4 INR556.1 INR0.20-5.3448.8KOff
10 Jul 2026387.0 INR1.1%390.9 INR557.5 INR0.22-6.8146.7KOff
3 Jul 2026382.6 INR2.4%391.3 INR558.9 INR0.17-8.698.6KOff
26 Jun 2026373.8 INR-3.3%392.0 INR560.4 INR0.12-10.640Off
19 Jun 2026386.7 INR3.2%394.0 INR561.9 INR0.18-7.993.8KOff
12 Jun 2026374.8 INR1.2%395.9 INR563.4 INR0.14-9.919.0KOff
5 Jun 2026370.2 INR-4.8%398.6 INR565.2 INR0.31-10.736.8KOff
29 May 2026389.0 INR1.7%401.9 INR566.9 INR0.59-7.6729.4KOff
22 May 2026382.5 INR-3.0%404.7 INR568.4 INR0.74-10.4641.8KOff
15 May 2026394.4 INR-14.6%407.4 INR569.9 INR0.87-8.12130.4KOff
8 May 2026461.6 INR13.2%409.4 INR571.3 INR0.864.2860.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context